Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ImmunoCellular Therapeutics
ImmunoCellular Therapeutics
What we know from BIO2017
BioPharma Dive
Fri, 06/23/17 - 11:30 am
BIO2017
M&A
Novartis
Novo Nordisk
Seattle Genetics
ImmunoCellular Therapeutics
A Look at Four Brain Cancer Companies for 2016
Yahoo
Mon, 01/4/16 - 12:24 pm
brain cancer
Del Mar
ImmunoCellular Therapeutics
Vascular Biogenics
Burzynski Research Institute
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting
Yahoo/PR NewsWire
Sun, 06/1/14 - 11:29 am
ImmunoCellular Therapeutics
ICT-107
glioblastoma
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
TheStreet.com
Mon, 03/3/14 - 11:55 am
glioblastoma multiforme
DCVax
Northwest Biotherapeutics
ICT-107
ImmunoCellular Therapeutics
ImmunoCellular: Is Approval Enough?
Seeking Alpha
Mon, 02/24/14 - 11:12 am
ImmunoCellular Therapeutics
ICT-107
DCVax®-L
Northwest Biotherapeutics
glioblastoma multiforme
Focus On Cancer Immunotherapy Results
Seeking Alpha
Sat, 01/25/14 - 10:58 am
cancer immunotherapy
ImmunoCellular Therapeutics
ICT-107
DCVax®-L
Northwest Biotherapeutics
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thu, 01/2/14 - 09:35 am
Bristol-Myers Squibb
Roche
brain cancer
CytRx
Celldex Therapeutics
ImmunoCellular Therapeutics
Northwest Biotherapeutics
glioblastoma multiforme
nivolumab
Yervoy
The Race To Develop A Brain Cancer Treatment Takes An Interesting Turn
Forbes
Fri, 12/27/13 - 01:01 pm
brain cancer
glioblastoma multiforme
ImmunoCellular Therapeutics
Northwest Biotherapeutics
CytRx
Celldex Therapeutics
aldoxorubicin
DCVax
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Inovio
Pharma CEOs
PDL-1
immunotherapy
Joseph Kim
Bristol-Myers Squibb
Roche
Dendreon
GSK
ImmunoCellular Therapeutics
Merck
Northwest Biotherapeutics
Immunocellular Shares Are Set For A Rebound
Seeking Alpha
Fri, 12/20/13 - 08:37 am
ImmunoCellular Therapeutics
ICT-107
Northwest Biotherapeutics
Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Mon, 12/16/13 - 08:06 am
Ziopharm
cancer
AbbVie
Amgen
Celgene
Celldex Therapeutics
Gilead Sciences
Immunogen
JNJ
ImmunoCellular Therapeutics
Pharmacyclics
Intrexon
Seattle Genetics
ImmunoCellular's ICT-107 Phase II: Patience Will Pay Off
Seeking Alpha
Wed, 12/11/13 - 11:21 am
ImmunoCellular Therapeutics
ICT-107
glioblastoma multiforme
An In-Depth Look At 3 Companies Fighting GBM Brain Cancer
Seeking Alpha
Mon, 12/9/13 - 03:11 pm
glioblastoma multiforme
Agenus
ImmunoCellular Therapeutics
Northwest Biotherapeutics
Celldex, ImmunoCellular Fall And Rise On Hype And Hope
Seeking Alpha
Wed, 11/27/13 - 08:31 am
ImmunoCellular Therapeutics
Celldex
rindopepimut
glioblastoma
ICT-107
ImmunoCellular Therapeutics Soars on Positive Brain Cancer Data
Wall St Cheat Sheet
Mon, 11/25/13 - 05:30 pm
ImmunoCellular Therapeutics
glioblastoma multiforme
brain cancer
ICT-107
Northwest Biotherapeutics Poses Onyx Like Potential
Seeking Alpha
Mon, 11/18/13 - 09:56 am
Northwest Biotherapeutics
Agenus
Celldex
ONYX Pharmaceuticals
ImmunoCellular Therapeutics
Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies
Seeking Alpha
Fri, 10/18/13 - 10:51 am
Celldex
ImmunoCellular Therapeutics
Enanta
Merrimack Pharmaceuticals
Vanda
Investing Smart: Biotechs, Effective Therapies And Shareholder-Friendly CEOs
Seeking Alpha
Wed, 10/2/13 - 10:15 am
biotech
Jazz Pharmaceuticals
Questcor
Spectrum Pharmaceuticals
NeoStem
NewLink Genetics
Dendreon
Galena Biopharma
Roche
ImmunoCellular Therapeutics
Which Of These Smaller Companies Could Roche Buy?
Motley Fool
Sat, 08/17/13 - 10:50 am
Roche
M&A
Celldex
ImmunoCellular Therapeutics
Immunomedics
Alexion
ImmunoCellullar Therapeutics' Immune Modifying Approach To Cancer Is Worth Watching
Seeking Alpha
Tue, 07/2/13 - 01:36 am
ImmunoCellular Therapeutics
cancer
Dendreon
ICT-107
Pages
1
2
3
4
next ›
last »